Aurobindo Pharma Q4FY23 Results: Consolidated PAT Rose to Rs 506.3 Cr
Aurobindo Pharma Limited Q4 results show a revenue rise from 6499.8 to 6607.9 crores, a 1.66% increase in growth. EPS…
Aurobindo Pharma Q4FY23 Results
Read More